Skip to content

Clinical trials

Phase 1/2 RNA Virus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: RNA Virus Infections Phase: Phase 1/2 Country / region: United States Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biolex Therapeutics, Inc.1
Celularity Incorporated1
Kara Chew1
Medicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
RNA Virus Infections4
Virus Diseases4
COVID-192
Coronavirus Infections2
Infections2
Respiratory Tract Diseases2
Respiratory Tract Infections2
Coronaviridae Infections1
Digestive System Diseases1
Flaviviridae Infections1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.